Search research articles
Contact Us
Filters
Showing results (421-430 of 562) with videos related to
Page
of 57
Sort By:
Neuro-Oncology Advances
|
January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial
Annika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
International Journal of Cancer
|
May 14, 2019
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells
Mor Varon, Tal Levy, Gal Mazor, et al.
Aging
|
November 21, 2014
Proteome-wide analysis reveals an age-associated cellular phenotype of in situ aged human fibroblasts
Daniel M Waldera-Lupa, Faiza Kalfalah, Ana-Maria Florea, et al.
Journal of Neurosurgery
|
March 3, 2005
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
Frank Willi Floeth, Dirk Pauleit, Hans-Jörg Wittsack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2017
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <i>EGFR</i>-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
Jörg Felsberg, Bettina Hentschel, Kerstin Kaulich, et al.
Acta Neuropathologica
|
November 26, 2009
Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system
Heidi V N Küsters-Vandevelde, Annelies Klaasen, Benno Küsters, et al.
Pharmacological Research
|
February 17, 2025
An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT)
David Pauck, Daniel Picard, Mara Maue, et al.
International Journal of Cancer
|
May 18, 2010
Molecular signatures classify astrocytic gliomas by IDH1 mutation status
Grischa Toedt, Sebastian Barbus, Marietta Wolter, et al.
Journal of Neurosurgery
|
February 16, 2022
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma
Hendrik-Jan Mijderwijk, Daan Nieboer, Fatih Incekara, et al.
Nature Communications
|
July 30, 2016
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
C Depner, H Zum Buttel, N Böğürcü, et al.
Page
of 57
Search research articles
Search
Showing results (421-430 of 562) with videos related to
Sort By:
Page
of 57
Neuro-Oncology Advances
|
January 6, 2025
Prognostic factors for overall survival in elderly patients with glioblastoma: Analysis of the pooled NOA-08 and Nordic trials with the CCTG-EORTC (CE.6) trial
Annika Malmström, Felix B Oppong, Christopher J O Callaghan, et al.
International Journal of Cancer
|
May 14, 2019
The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells
Mor Varon, Tal Levy, Gal Mazor, et al.
Aging
|
November 21, 2014
Proteome-wide analysis reveals an age-associated cellular phenotype of in situ aged human fibroblasts
Daniel M Waldera-Lupa, Faiza Kalfalah, Ana-Maria Florea, et al.
Journal of Neurosurgery
|
March 3, 2005
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
Frank Willi Floeth, Dirk Pauleit, Hans-Jörg Wittsack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2017
Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in <i>EGFR</i>-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors
Jörg Felsberg, Bettina Hentschel, Kerstin Kaulich, et al.
Acta Neuropathologica
|
November 26, 2009
Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system
Heidi V N Küsters-Vandevelde, Annelies Klaasen, Benno Küsters, et al.
Pharmacological Research
|
February 17, 2025
An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT)
David Pauck, Daniel Picard, Mara Maue, et al.
International Journal of Cancer
|
May 18, 2010
Molecular signatures classify astrocytic gliomas by IDH1 mutation status
Grischa Toedt, Sebastian Barbus, Marietta Wolter, et al.
Journal of Neurosurgery
|
February 16, 2022
Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma
Hendrik-Jan Mijderwijk, Daan Nieboer, Fatih Incekara, et al.
Nature Communications
|
July 30, 2016
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance
C Depner, H Zum Buttel, N Böğürcü, et al.
Page
of 57